New York State Common Retirement Fund »

Acrivon Therapeutics shares owned by New York State Common Retirement Fund

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by New York State Common Retirement Fund from 13F filings

Historical chart of New York State Common Retirement Fund investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by New York State Common Retirement Fund consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by New York State Common Retirement Fund

Quarter filed Position value Share count Share price at filing
2023-12-31 $11k 2.3k 4.84
2023-09-30 $22k 2.3k 9.58
2023-06-30 $29k 2.3k 12.75
2023-03-31 $28k 2.2k 12.69

More positions owned by New York State Common Retirement Fund

Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Nvidia Corporation Common Stock (NVDA)
Alphabet Inc - Class A Common Stock (GOOGL)
Meta Platforms Common Stock (META)
Alphabet Inc - Class C Common Stock (GOOG)
Tesla Common Stock (TSLA)
Berkshire Hathaway Inc-cl Common Stock (BRK.B)
Unitedhealth Group Common Stock (UNH)
Eli Lilly & Company Common Stock (LLY)
Jp Morgan Chase & Company Common Stock (JPM)
Broadcom Common Stock (AVGO)
Visa Inc - Class A Common Stock (V)
Mastercard Inc Class A Common Stock (MA)

View all positions for New York State Common Retirement Fund

Top funds holding Acrivon Therapeutics

RA Capital Management
Perceptive Advisors
Citadel Advisors
Wellington Management Company
Marshall Wace
Vanguard Group
NEA Management Company
Federated Investors
DAFNA Capital Management
Charles Schwab Investment Management
Exchange Traded Concepts
Jacobs Levy Equity Management
Jpmorgan Chase & Co
D. E. Shaw & Co
Barclays

View all funds holding Acrivon Therapeutics